EndoBarrier is currently available in our London, Manchester and Southampton clinics.

The facts about Type 2 Diabetes

Type 2 Diabetes is a progressive disease characterized by increasing levels of glucose in the blood caused by development
of cellular resistance to insulin and decline in ß-cell function.

When ß-cell function declines to the point that the patient requires insulin, a normally chronic disease becomes a disease with acute treatment needs.

It manifests clinically by deterioration in clinical parameters including glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and postprandial glucose levels. HbA1c will increase by about 1% every two years even with existing pharmacological therapies.

Since every 1% increase in HbA1c increases cardiovascular and neurological health risks by as much as 21%, there is a significant need to drive glucose levels to the normal range and to maintain them as long as possible.